Arif Akyildiz

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 10

Top Topics

Locally Advanced

Ejection Fraction

Metastatic Breast Cancer

Top Venues

Pharmaceuticals (Basel, Switzerland)

International journal of gynecological cancer : official journal of the International Gynecological Cancer Society

Annals of hematology

This page only lists publications with an associated author ORCID identifier.

Publications

Arif Akyildiz, Melis Gultekin, Ecem Yigit, Ecem Demir, Rashad Ismayilov, Melin Aydan Ahmed, Mustafa Buyukkor, Hasan Cagrı Yıldırım, Nilgun Yıldırım, Gokhan Ucar, Efnan Algin, Ahmet Emin Ozturk, Sinem Akbas, Fatih Selcukbiricik, Seval Orman, Nedim Turan, Mesut Yilmaz, Rumeysa Colak, Esra Ozen Engin, Nargiz Majidova, Ibrahim Vedat Bayoglu, Havva Beyaz, Ozturk Ates, Kamuran Ibıs, Sefika Arzu Ergen, Sezin Yuce Sari, Yilmaz Tezcan, Ferah Yildiz, Zafer Arik
Efficacy of cumulative cisplatin dose on survival in patients with locally advanced cervical cancer treated with definitive chemoradiotherapy: multicenter study by Turkish Oncology Group. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 34 (9) (2024)
Taha Koray Sahin, Arif Akyildiz, Osman Talha Dogan, Gozde Kavgaci, Deniz Can Guven, Sercan Aksoy
Prognostic Significance of Pan-Immune-Inflammation Value in Patients with HER2-Positive Metastatic Breast Cancer Treated with Trastuzumab Emtansine. Pharmaceuticals (Basel, Switzerland) 17 (7) (2024)
Taha Koray Sahin, Arif Akyildiz, Osman Talha Dogan, Gozde Kavgaci, Deniz Can Guven, Sercan Aksoy
Prognostic Significance of Pan-Immune-Inflammation Value in Patients with HER2-Positive Metastatic Breast Cancer Treated with Trastuzumab Emtansine. Pharmaceuticals (Basel, Switzerland) 17 (7) (2024)
Taha Koray Sahin, Arif Akyildiz, Osman Talha Dogan, Gozde Kavgaci, Deniz Can Guven, Sercan Aksoy
Prognostic Significance of Pan-Immune-Inflammation Value in Patients with HER2-Positive Metastatic Breast Cancer Treated with Trastuzumab Emtansine. Pharmaceuticals (Basel, Switzerland) 17 (7) (2024)
Arif Akyildiz, Melis Gultekin, Ecem Yigit, Ecem Demir, Rashad Ismayilov, Melin Aydan Ahmed, Mustafa Buyukkor, Hasan Cagrı Yıldırım, Nilgun Yıldırım, Gokhan Ucar, Efnan Algin, Ahmet Emin Ozturk, Sinem Akbas, Fatih Selcukbiricik, Seval Orman, Nedim Turan, Mesut Yilmaz, Rumeysa Colak, Esra Ozen Engin, Nargiz Majidova, Ibrahim Vedat Bayoglu, Havva Beyaz, Ozturk Ates, Kamuran Ibıs, Sefika Arzu Ergen, Sezin Yuce Sari, Yilmaz Tezcan, Ferah Yildiz, Zafer Arik
Efficacy of cumulative cisplatin dose on survival in patients with locally advanced cervical cancer treated with definitive chemoradiotherapy: multicenter study by Turkish Oncology Group. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society (2024)
Arif Akyildiz, Deniz Can Guven, Baris Koksal, Beliz Bahar Karaoglan, Derya Kivrak, Rashad Ismayilov, Firat Aslan, Osman Sutcuoglu, Ozan Yazici, Ahmet Kadioglu, Ozkan Alan, Nargiz Majidova, Mert Erciyestepe, Erkan Ozcan, Goncagul Akdag, Hakan Taban, Ali Osman Kaya, Murad Guliyev, Nilgun Yildirim, Teoman Sakalar, Dogan Yazilitas, Caglar Unal, Sercan On, Sedat Biter, Nebi Serkan Demirci, Filiz Cay Senler, Yasemin Kemal, Omer Diker Halil, Ibrahim Gullu, Sercan Aksoy
Real-world evaluation of nivolumab in patients with non-nasopharyngeal recurrent or metastatic head and neck cancer: a retrospective multi-center study by the Turkish Oncology Group (TOG). European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery (2024)
Arif Akyildiz, Rashad Ismayilov, Nargiz Rustamova, Mert Tokatlı, İrem Koç, Serkan Akın, Hayyam Kıratlı, Ibrahim Barista
Comprehensive analysis of orbital lymphoma in a Turkish cohort: clinical characteristics, histological subtypes, treatment modalities, prognostic factors, and implications for management. Annals of hematology (2023)
Arif Akyildiz, Deniz Can Guven, Hasan Cagri Yildirim, Rashad Ismayilov, Feride Yilmaz, Omer Denizhan Tatar, Elvin Chalabiyev, Fatih Kus, Suayib Yalcin, Sercan Aksoy
Do statins enhance the antitumor effect of trastuzumab emtansine (T-DM1)?: Real-life cohort. Medicine 102 (18) (2023)
Fatih Kus, Deniz Can Guven, Hasan Cagrı Yıldırım, Elvin Chalabiyev, Arif Akyildiz, Omer Denizhan Tatar, Yigit B Sahin, Serez Ileri, Ece Karaca, Neyran Kertmen, Zafer Arik
KELIM score predicts outcome in patients with platinum-resistant/refractory recurrent ovarian cancer. Biomarkers in medicine (2023)
Arif Akyildiz, Deniz Can Guven, Ahmet Anil Ozluk, Rashad Ismayilov, Emel Mutlu, Olcun Umit Unal, Ibrahim Yildiz, Yakup Iriagac, Serdar Turhal, Sinem Akbas, Ertugrul Bayram, Tugba Akin Telli, Fatma Paksoy Turkoz, Melike Ozcelik, Mert Erciyestepe, Oguzhan Selvi, Burcu Gulbagci, Ismail Erturk, Zehra Sucuoglu Isleyen, Seda Kahraman, Mutianur Ozkorkmaz Akdag, Buket Hamitoglu, Ilkay Tugba Unek, Caglar Unal, İlhan Hacibekiroglu, Cagatay Arslan, Abdulmunir Azizy, Kaan Helvaci, Umut Demirci, Omer Dizdar, Mert Basaran, Erdem Goker, Mehmet Ali Sendur, Suayib Yalcin
The safety and efficacy of first-line atezolizumab plus bevacizumab in patients with unresectable hepatocellular carcinoma: A multicenter real-world study from Turkey. Medicine 102 (45) (2023)